EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Premedication with Lugol’s solution in total thyroidectomy for graves’ disease and toxic multinodular goiter: is it still indicated?

D Ciriotto, S Bernardi, R Eramo, V Calabrò, A Modica, N de Manzini, C Dobrinja

Updates in Surgery · 2026

DOI: 10.1007/s13304-025-02475-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Updates in Surgery, 2026. Verfasst von D Ciriotto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Surgery, ASUGI, Cattinara Teaching Hospital, Trieste, Italy. Hauptthemen laut MEDLINE: Thyroidectomy, Graves Disease, Goiter, Nodular, Iodides. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Trieste.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premedication with Lugol’s solution (LS) has traditionally been used to reduce the vascularization and friability of the thyroid gland before total thyroidectomy in patients with Graves’ disease (GD) and toxic multinodular goiter (TMNG) with thyrotoxicosis and/or with undetectable serum TSH. However, the effectiveness and applicability of this treatment remain subjects of debate. This study aims to evaluate the surgical and postoperative outcomes in patients premedicated with LS compared to those who were not premedicated. Data from 100 patients who underwent total thyroidectomy for GD and TMNG at our center from 2014 to 2024 were analyzed. Patients were divided into two groups: Lugol+, premedicated with LS ( n = 57), and Lugol−, not premedicated ( n = 43). Variables analyzed included thyroid diameter, thyroid weight, operative time, postoperative hemorrhage, hypocalcemia, recurrent laryngeal nerve palsy, length of hospital stay, rate of reintervention for hemorrhage, intraoperative thyroid consistency. No statistically significant differences were found between the groups regarding postoperative hemorrhage (1.7% in Group Lugol+ vs. 2.3% in Group Lugol−), operative time (median: 95 vs. 85 min), immediate postoperative complications such as transient hypoparathyroidism (15.8% vs. 9.3%) and transient recurrent laryngeal nerve (RLN) palsy (3.5% vs. 2.3%), nor the other variables analyzed. Our data suggest that routine preoperative preparation with LS may not be mandatory. This study supports the thesis that patients with GD and TMNG who cannot be premedicated due to inability to obtain LS, insufficient time for preoperative preparation, or lesser compliance by patient, may still be eligible for surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyroidectomyGraves DiseaseGoiter, NodularIodidesPremedicationHumansMaleFemaleMiddle AgedAdultTreatment OutcomeRetrospective StudiesPostoperative ComplicationsAged

Stichwörter der Autor:innen

Graves’ diseaseLugol’s solutionPremedicationSurgical complications.Total thyroidectomyToxic multinodular goiter

Substanzen

Lugol's solutionIodides

Autor:innen und Institutionen

  • Division of General Surgery, ASUGI, Cattinara Teaching Hospital, Trieste, Italy.
  • Division of General Surgery, Department of Medicine, Surgery and Health Sciences, Cattinara Teaching Hospital, University of Trieste, Strada di Fiume 447, 34149, Trieste, Italy.
  • SS Endocrinologia, UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste, Italy.
  • Division of General Surgery, ASUGI, Cattinara Teaching Hospital, Trieste, Italy. chiara.dobrinja@units.it.
  • Division of General Surgery, Department of Medicine, Surgery and Health Sciences, Cattinara Teaching Hospital, University of Trieste, Strada di Fiume 447, 34149, Trieste, Italy. chiara.dobrinja@units.it.

Förderung

  • Università degli Studi di Trieste

Zitieren

APA

Ciriotto, D., Bernardi, S., Eramo, R., Calabrò, V., Modica, A., de Manzini, N., & Dobrinja, C. (2026). Premedication with Lugol’s solution in total thyroidectomy for graves’ disease and toxic multinodular goiter: is it still indicated?. Updates in Surgery. https://doi.org/10.1007/s13304-025-02475-9

Vancouver

Ciriotto D, Bernardi S, Eramo R, Calabrò V, Modica A, de Manzini N, et al. Premedication with Lugol’s solution in total thyroidectomy for graves’ disease and toxic multinodular goiter: is it still indicated?. Updates in Surgery. 2026. doi:10.1007/s13304-025-02475-9

BibTeX
@article{Ciriotto2026,
  author = {Ciriotto, D and Bernardi, S and Eramo, R and Calabrò, V and Modica, A and de Manzini, N and Dobrinja, C},
  title = {Premedication with Lugol’s solution in total thyroidectomy for graves’ disease and toxic multinodular goiter: is it still indicated?},
  journal = {Updates in Surgery},
  year = {2026},
  doi = {10.1007/s13304-025-02475-9}
}
Kostenlos starten →